Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00402688 · ClinicalTrials.gov registry record · Phase 3
An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis
A Phase 3 study, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
- Completed
- Registry status
- Phase 3
- Development phase
- 242
- Enrollment target
NCT00402688 is a Phase 3 study that has completed, run by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.. The registered enrollment target is 242 participants.
The verdict
NCT00402688, a Phase 3 study, has completed, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 242 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and effectiveness of levofloxacin 750 mg for 2 weeks or 750 mg for 3 weeks, compared to levofloxacin 500 mg for 4 weeks in the treatment of chronic prostatitis.
Interventions
- DRUG levofloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00402688
The ClinicalTrials.gov registry entry for NCT00402688 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has 102 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which levofloxacin is the first listed.
NCT00402688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00402688 about?
NCT00402688 is a clinical study titled "An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis". The purpose of this study is to compare the safety and effectiveness of levofloxacin 750 mg for 2 weeks or 750 mg for 3 weeks, compared to levofloxacin 500 mg for 4 weeks in the treatment of chronic prostatitis.
What is the current status of trial NCT00402688?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 242 participants. The study started on 2006-11. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00402688?
The interventions under investigation include: levofloxacin (DRUG).
Who is sponsoring clinical trial NCT00402688?
This trial is sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has 102 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.